Resalis Therapeutics logo
VerifiedBiotechnology Research· Founded 2021

Resalis Therapeutics

Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.

7-day free trial · no credit card

HeadquartersTurin, ItalyEmployees11(1 to 10)Founded year2021Websiteresalistherapeutics.comLinkedIn profileLinkedIn

Verified contacts

8

available on Kipplo

LinkedIn employees

11

1 to 10 range

Open roles

no listings

Distinct roles

7

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 8 verified contacts at Resalis Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

8 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Resalis Therapeutics

7 distinct titles indexed · top 7 shown.

  • 2junior business analyst
  • 1chief executive officer e amministratore delegato
  • 1head of operations
  • 1project coordinator & budget planner
  • 1project manager
  • 1publication lead
  • 1translational research associate

Sign up to unlock all 8 contacts at Resalis Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 8 verified contacts at Resalis Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Resalis Therapeutics | Kipplo Discover